The Signal Sequence of Exported Protein-1 Directs the Green Fluorescent Protein to the Parasitophorous Vacuole of Transfected Malaria Parasites*

Akinola AdisaDagger , Melanie RugDagger , Nectarios KlonisDagger §, Michael FoleyDagger §, Alan F. Cowman, and Leann TilleyDagger §||

From the Dagger  Department of Biochemistry and § Co-operative Research Center for Diagnostics, La Trobe University, Bundoora, 3086, Victoria, Australia and  Infection and Immunity, Walter and Eliza Hall Institute of Medical Research, PO RMH, 3052, Victoria, Australia

Received for publication, July 15, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The malaria parasite, Plasmodium falciparum, spends part of its life cycle inside the erythrocytes of its human host. In the mature stages of intraerythrocytic growth, the parasite undertakes extensive remodeling of its adopted cellular home by exporting proteins beyond the confines of its own plasma membrane. To examine the signals involved in export of parasite proteins, we have prepared transfected parasites expressing a chimeric protein comprising the N-terminal region of the Plasmodium falciparum exported protein-1 appended to green fluorescent protein. The majority of the population of the chimeric protein appears to be correctly processed and trafficked to the parasitophorous vacuole, indicating that this is the default destination for protein secretion. Some of the protein is redirected to the parasite food vacuole and further degraded. Photobleaching studies reveal that the parasitophorous vacuole contains subcompartments that are only partially interconnected. Dual labeling with the lipid probe, BODIPY-TR-ceramide, reveals the presence of membrane-bound extensions that can bleb from the parasitophorous vacuole to produce double membrane-bound compartments. We also observed regions and extensions of the parasitophorous vacuole, where there is segregation of the lumenal chimera from the lipid components. These regions may represent sites for the sorting of proteins destined for the trafficking to sites beyond the parasitophorous vacuole membrane.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Due to the compartmentalization of eukaryotic cells, a sophisticated protein trafficking system is an integral requirement for homeostasis and growth. Proteins destined for compartments other than the cytoplasm are synthesized with intrinsic signals that determine their transport within the cell. Small peptide motifs often form the necessary targeting determinants (1). For example, an N-terminal hydrophobic sequence forms part of the typical secretory signal that directs proteins across the endoplasmic reticulum (ER)1 membrane (2-5). Similarly, N-terminal amphipathic and bipartite sequences target proteins to the chloroplast and mitochondria (6-8).

The malaria parasite, Plasmodium falciparum, spends part of its life cycle inside mature human erythrocytes. The parasite invades this quiescent host cell and develops within a parasitophorous vacuole (PV). An unusual and highly specialized secretory system enables the malaria parasite to survive within a cell that lacks its own machinery for protein synthesis and trafficking. Indeed, the parasite targets proteins, not only to compartments within its own confines, but to the PV, in which it resides, as well as the PV membrane (PVM), the erythrocyte cytoplasm, and host cell membrane (9-11).

Efforts have been made to understand the trafficking signals that target parasite proteins to different compartments within and outside the parasite. Proteins destined for the ER, the parasite plasma membrane (PPM), the PV, or the PVM appear to have a "classical" hydrophobic N-terminal signal sequence (i.e. a stretch of 10-15 hydrophobic amino acids commencing 3-17 amino acids from the N terminus) (12, 13). For example, the secretory signal of the PVM-located integral membrane protein, exported protein-1 (Exp1, also called antigen 5.1, QF119, or cross-reactive antigen) has a characteristic N-terminal signal (14), which is cleaved by the malaria parasite at a site adjacent to glutamate 23 (15). This signal sequence is recognized by the translocation machinery of higher eukaryotes (16). However, a number of proteins that are directed past the PVM to the erythrocyte cytosol do not have classical N-terminal signals. Instead, proteins such as the knob-associated histidine-rich protein (KAHRP) have a hydrophobic stretch of amino acids starting 20-80 amino acids from the N terminus (13, 17). This "internal" hydrophobic signal does not appear to function in heterologous trafficking systems, since KAHRP is not translocated across the ER membrane in a cell-free system using mammalian microsomes (9, 16, 18).

Recently, the development of the technology for transfection of malaria parasites has permitted an analysis of the signals that direct proteins to different compartments. For example, Wickham et al. (19) prepared a series of constructs in which gene fragments encoding the N-terminal regions of KAHRP were appended to the reporter protein, green fluorescent protein (GFP). These constructs were introduced into P. falciparum using a stable transfection system (8, 19, 20), and the locations of the proteins were assessed by fluorescence microscopy. The studies indicated that the atypical N-terminal signal sequence of KAHRP contains information that is both necessary and sufficient for entry into the ER and trafficking to the PV. These studies suggested that secretion into the PV is the default pathway for export of proteins in the malaria parasite. The studies of Wickham et al. (19) also indicated that a separate sequence element in the histidine-rich region of KAHRP is needed for the translocation of this protein across the PVM. Trafficking of proteins to the erythrocyte cytosol appears to be a two-step process, with the PV acting as an intermediate compartment (19, 21). Following release into the erythrocyte cytosol, soluble KAHRP appears to associate briefly with the cytoplasmic surface of Maurer's clefts and eventually is assembled into "knob" structures underneath the erythrocyte membrane (19).

A separate transfection study employed constructs encoding the classical N-terminal signal sequence of Exp1 appended to luciferase (22). Using a transient transfection system and a sensitive biochemical assay for detection of the luciferase tag, these authors reported that about 40% of the tagged Exp1 was directed to the PV and about 60% to the erythrocyte cytosol. The authors concluded that export of parasite proteins to the erythrocyte cytosol represents the default pathway for protein transport and that additional signal sequence information is required to trap the exported proteins in the PV.

The discrepancy between the data obtained from these two experimental approaches prompted us to reexamine the Exp1 signal sequence in a stable transfection system using GFP as the reporter. In this work, we have prepared a construct encoding the N-terminal signal sequence of Exp1 fused to GFP and used the plasmid to transfect P. falciparum-infected erythrocytes. Our results confirm that transit through the ER to the PV is the default pathway for protein trafficking. Using dual labeling with the lipid probe, BODIPY-TR-ceramide, we demonstrate that protrusions from the PV extend into the erythrocyte cytoplasm and occasionally bud to form mobile vesicular compartments containing PV components. The lipid probe was also used to identify subcompartments of the PV that do not contain the GFP chimera.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

PCR and Cloning-- The sequence of P. falciparum exported antigen-1, Exp1, was obtained from the National Center for Biotechnology Information data base (available on the World Wide Web at www.ncbi.nlm.nih.gov/BLAST/; accession number P04926) (23, 24). The sequence encoding amino acid residues 1-35 of Exp1 of P. falciparum 3D7 strain (EXP1-(1-105)) was amplified by PCR from genomic DNA using primers: 5'-AGA TCT ATG AAA ATC TTC TTA TCA GTA TTT TTT C and 5'-CCT AGG GCT GCT AAC ACC ACT TCC AGT TTC (restriction sites are underlined). The resulting fragment, bearing the BglII and AvrII restriction sites, was first cloned into the pCR2.1 TOPO vector (Invitrogen) and then placed upstream of the mut 2 EGFP coding region in the pHH2 vector (EXP1-(1-105)-GFP-pHH2) (8, 19). The insert was sequenced in both directions using fluorescent dideoxynucleotide termination.

P. falciparum Culture and Transfection-- P. falciparum-infected erythrocytes (ring stage, 3D7 strain) were transfected with the EXP1-(1-105)-GFP-pHH2 plasmid and cultured in the presence of WR99210 (10 nM) as described by Wickham et al. and Fidock et al. (19, 25). Parasites expressing the GFP chimeric protein (Exp1-(1-35)-GFP) were obtained 55 days after transfection and thereafter maintained in the presence of 100 pM WR99210. Harvesting and brefeldin A (BFA) treatment of parasites was carried out as described by Adisa et al. (26).

Subcellular Fractionation of Transfectants-- Transfectants were cultured to a parasitemia of 10% rings and then synchronized using sorbitol treatment. To ensure tight synchronization, the parasites were treated with sorbitol, allowed to develop for several hours, and then treated with sorbitol again. These synchronous parasites were cultured for a further 24 h (trophozoite stage) and harvested on a Percoll-sorbitol cushion as described by Aley et al. (27). To release the erythrocyte contents, ~5 × 107 parasites were treated with either 450 or 900 units of streptolysin O (SLO; Sigma; corresponding to 4 or 8 hemolytic units, as defined by Baumeister et al. (28)) and separated into pellets and supernatants as described by Ansorge et al. (21, 29) and Burghaus and Lingelbach (22). To release the erythrocyte and PV contents, 5 × 107 parasites were subjected to lysis in the presence of 0.09% saponin (Sigma) and separated into soluble and particulate fractions by centrifugation (21). Equivalent fractional amounts of each of the samples were subjected to SDS-PAGE and Western analysis.

Antibodies and Lipid Probes-- Western blot analyses were performed as previously described (26) using antibodies recognizing GFP (murine monoclonal; Roche Molecular Biochemicals), P. falciparum S-antigen (rabbit antiserum against 3D7 strain obtained from Prof. Robin Anders, La Trobe University) and Exp1 (rabbit antiserum kindly provided by Prof. Klaus Lingelbach, Philipps-University, Marburg, Germany). For immunoblot analyses, asynchronous P. falciparum cultures were harvested, subjected to SDS-PAGE (12% acrylamide), transferred to polyvinylidene difluoride membrane, probed with antiserum followed by horseradish peroxidase-conjugated secondary antibodies (Sigma), and developed with enhanced chemiluminescence (ECL) reagent. BODIPY-TR-ceramide was obtained from Molecular Probes and used to label parasitized erythrocytes as described by Behari and Haldar (30). Briefly, parasitized erythrocytes were resuspended in complete medium (5% parasitemia, 10% hematocrit) and incubated in the presence of 1 µM BODIPY-TR-ceramide in complete medium at 37 °C for 60 min, washed three times in complete medium and examined by fluorescence microscopy. The extent of conversion of the exogenously added ceramide to sphingomyelin was assessed by extracting the lipids and subjecting them to thin-layer chromatography as described by Haldar et al. (31).

Confocal Fluorescence Microscopy-- Parasitized erythrocytes expressing Exp1-(1-35)-GFP were mounted wet on a glass slide, covered by a glass coverslip, and imaged within 20 min at ambient temperature (maintained at 20 °C) using a Leica TCS confocal microscope (Confocal Imaging Facility, Monash University, Clayton, Australia) equipped with a ×100 planapochromatic oil immersion objective (1.4 numerical aperture). The 488- and 568-nm lines of a 60-milliwatt krypton-argon laser were used to excite GFP and BODIPY-TR, respectively. The fluorescence from each probe was detected through a 530/30-nm band pass filter and a 590-nm long pass filter, respectively. Differential interference contrast (DIC) images were generated using the transmitted light.

Photobleaching experiments were typically conducted as follows. Two prebleach images were obtained, and the laser was focused on a single spot (representing a diffraction-limited point) defined on the prebleach image. The point was illuminated for a specified time (1 s) using a bleach pulse at maximum laser power at the excitation wavelength characteristic of the fluorophore to be bleached. In the case of fluorescence recovery after photobleaching (FRAP) measurements, postbleach images were obtained immediately after the high intensity illumination (delay ~1 s) and at time intervals after bleaching. For fluorescence loss in photobleaching (FLIP) measurements, four high intensity bleach pulses were applied at 30-s intervals prior to the acquisition of each image. The gain on the photomultiplier was kept high, and the laser power was adjusted using an acousto-optical tunable filter to a level sufficient to minimize photobleaching of the sample during image acquisition. Images were typically obtained at 0.049-nm pixel resolution and were the average of four acquisitions (~2-s total image acquisition time).

Image Analysis-- Confocal images were processed and analyzed using ImageJ software (available on the World Wide Web at rsb.info.nih.gov/ij). For photobleaching measurements, images were processed using a median filter followed by smoothing (both employing a 1-pixel radius) to improve the signal/noise ratio and were corrected for background. The images were also corrected for the small degree of bleaching occurring during image acquisition using a correction factor obtained from the intensity of the two prebleach images and applying it exponentially to the remaining images. The bleaching between successive images was typically 2-5%. Two criteria were rigorously employed when quantitating the intensity of regions of interest between successive images: (i) the regions of interest should not contain saturated pixel values (i.e. all pixel values should be less than 255), and (ii) there should be no significant movement of the regions analyzed. Note that the confocal images presented in this paper have been adjusted for presentation purposes to highlight and accentuate features of interest and do not represent the actual images analyzed.

The spatial distribution of bleaching was visualized by constructing a bleach (B) image from a prebleach (PRE) and a postbleach (POST) image as follows,
B<SUB>(x,y)</SUB>=255 (PRE<SUB>(x,y)</SUB>−POST<SUB>(x,y)</SUB>)/PRE<SUB>(x,y)</SUB> (Eq. 1)
where B, PRE, and POST represent the pixel intensities at the x and y pixel coordinates of the respective images. The spatial distribution of the fluorescence recovery following bleaching was visualized using a Quench/Recovery (QR) image. This was generated from a prebleach (PRE) image and postbleach images obtained immediately after bleaching (POST0) and at time t following bleaching (POSTt).
QR<SUB>(x,y)</SUB>=128+128 (POST<SUB>t(x,y)</SUB>−POST<SUB>0(x,y)</SUB>)/PRE<SUB>(x,y)</SUB> (Eq. 2)

The differences between the postbleach images are normalized relative to the prebleach image. Regions that increase in value (i.e. exhibit recovery) appear blue, whereas regions that decrease in value (i.e. are quenched) appear red using the lookup table shown in Fig. 9. In the case of B and QR images, only regions of interest within the image that did not appear to move during the course of the measurements were visualized in the image.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Amino Acids 1-35 of Exp1, When Fused to GFP, Allow Secretion of the Chimera in Transfected P. falciparum-- The arrangement of the gene and the protein sequence encoded by EXP1 (3D7 strain) are shown in Fig. 1. Exon 1 of the EXP1 gene encodes the first 40 amino acids of the protein (Fig. 1, A and B). The first 22 amino acids of this protein have been shown to comprise a classical signal sequence that functions both in vivo and in vitro to direct proteins into the ER (14-16).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 1.   Organization of the EXP1 gene and gene product. A, schematic diagram of the EXP1 gene. Exons 1-3 are indicated by rectangles, and introns and gene flanking sequences are shown by solid lines. B, amino acid sequence of 3D7 Exp1. The N-terminal signal sequence (which terminates at the proteolytic cleavage site) is underlined, and the hydrophobic core of the signal is double underlined. The putative transmembrane region is in italics. C, the N-terminal 35-amino acid fragment of Exp1 appended to GFP (Exp1-(1-35)-GFP). It is likely that the signal peptidase in the ER processes the chimera to a mature form.

Recently, it has been suggested that the N-terminal region of Exp1 also contains sequence elements that direct the protein beyond the PV (22). To further examine this suggestion, we generated a chimera comprising an N-terminal fragment of Exp1 linked to the reporter GFP. A portion of the EXP1 gene that encodes the first 35 amino acids of the protein was joined upstream of the mut 2 enhanced GFP coding sequence in the transfection vector pHH2 (pHH2-EXP1-(1-35)-GFP) (Fig. 1C). This region of Exp1 includes the signal sequence comprising 13 hydrophobic amino acids flanked by charged residues and the cleavage site between residues 22 and 23. The resultant GFP fusion protein was expressed from a stably maintained episome (8, 19) within the transformed 3D7 P. falciparum blood stage parasites.

Parasites expressing the GFP chimeric protein (Exp1-(1-35)-GFP) were obtained 55 days after transfection and were maintained in culture in the presence of a 10 nM concentration of the antifolate drug, WR99210. They showed similar growth rates to untransfected parasites and maintained the plasmid even under lower (100 pM) drug concentrations. This suggests that the expression of the GFP chimera did not confer a growth disadvantage on the parasites.

To confirm expression of the Exp1-(1-35)-GFP fusion protein in the P. falciparum transfectants, we performed Western blots on parasite-infected erythrocytes (Fig. 2). When probed with antibodies recognizing GFP, no reactivity was observed in uninfected erythrocytes or in the untransfected parental line, 3D7. By contrast, the transfected parasites expressed proteins that were resolved as a doublet of ~28 and 26 kDa. The predicted size of the full-length Exp1-(1-35)-GFP chimera is 30 kDa. It is likely that the 28-kDa band represents a processed form of Exp1-(1-35)-GFP in which the 22-amino acid signal sequence has been removed. The 26-kDa band presumably represents a further degradation product. Lower molecular weight degradation products of GFP chimeras have been reported previously (8, 19).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2.   Western blot analysis of parasites transfected with the Exp1-(1-35)-GFP construct. Total cell lysates from ~106 cells (10% parasitemia) were lysed by freezing and thawing and subjected to electrophoresis (10-15% acrylamide), transferred to polyvinylidene difluoride membrane, and probed with anti-GFP antibody (Roche Molecular Biochemicals; 1:1000 dilution). UI, UT, and TR represent uninfected erythrocytes and untransfected and transfected parasitized erythrocytes, respectively.

The expression of the Exp1-(1-35)-GFP reporter in different stages of the intraerythrocytic cycle of transfected P. falciparum was examined using confocal fluorescence microscopy (Fig. 3). The Exp1-(1-35)-GFP chimera is expressed under the control of the hsp86 promoter and is thus produced at all stages of intraerythrocytic growth (32). By contrast, endogenous Exp1 is expressed most strongly in mature stage parasites (33) (data not shown). The protein appears to be largely located in the PV that surrounds the parasite (Fig. 3). Some parasites showed a "necklace of beads" pattern around the periphery of the parasite (Fig. 3, B and D) as has been reported previously for a chimera of an N-terminal fragment of KAHRP with GFP (19). In some doubly infected erythrocytes (Fig. 3B), only one of the parasites appeared to be expressing the transfection construct. The second parasite has presumably expelled the plasmid but is protected from the deleterious effects of WR99210 by its sister parasite. In more mature stages of the intraerythrocytic development of the parasite, protrusions from the PV were commonly observed (Fig. 3, B, C, and E). The protrusions largely appeared to remain connected to the PV. As suggested previously (19), the short protrusions of the PV may reflect evaginations of the PV into blind appendices that form part of the tubulovesicular network (TVN). In some cells, fluorescence was also observed in a compartment within the cytoplasm of the parasite, which appears to be the food vacuole (FV) (Fig. 3, C and E). In the schizont stage, a segmented pattern around a highly fluorescent central remnant body was obtained (Fig. 3F). This indicates that the fusion protein surrounds the individual merozoites, which again is consistent with trafficking of the protein to the PV. These results suggest that the first 35 amino acids of the Exp1 protein are sufficient for entry into the secretory system and secretion from the parasite into the PV but do not contain information that would direct the protein into the erythrocyte cytosol.


View larger version (67K):
[in this window]
[in a new window]
 
Fig. 3.   Expression of Exp1-(1-35)-GFP chimeric proteins at different stages of the intraerythrocytic life cycle of P. falciparum. The first image in each set represents the DIC image, and the second is the fluorescence signal from the GFP chimeric protein, with an overlay of these images in the third panel. A, ring stage parasite showing PV labeling. B, erythrocyte infected with two late ring stage parasites, only one of which is expressing the Exp1-(1-35)-GFP transgene. The fluorescence signal resembles a necklace of "beads," some of which are marked with arrows. C-E, trophozoite stage parasites showing PV expression. Some cells retain the necklace of beads pattern (D). In some cases, distortions and evaginations of the PV were observed (C and E, yellow arrowheads). In some cells, GFP was observed in the FV (C and E, blue arrowheads). F, schizonts show a segmented pattern with a highly fluorescent central remnant body. Fluorescence from GFP was captured in live cells using a Leica TCS NT confocal microscope. Bar, 5 µm.

Exp1-(1-35) Is Present in the PV and FV of Transfected P. falciparum but Is Not Released into the Erythrocyte Cytosol-- The volume of the erythrocyte cytosol is much larger than that of the PV (22). Therefore, it remained formally possible that a significant proportion of the Exp1-(1-35) chimera was exported as a soluble protein to the erythrocyte cytosol but was below the level of detection using fluorescence microscopy. In order to confirm the location of the reporter protein, transfected parasites were subjected to selective permeabilization protocols employing SLO and saponin. Treatment of the transfected parasitized erythrocytes with 4 or 8 hemolytic units of SLO released more than 97% of the hemoglobin from the parasitized erythrocytes (data not shown), but did not release PfERC (Fig. 4C), which has previously been shown to be located within the ER lumen (34). S-antigen (a PV marker (35)) was also largely associated with the pellet fraction (0.5 and 4% in the supernatant, respectively, for 4 and 8 units of SLO; Fig. 4B). The trace amount of S-antigen that is released may be due to a small percentage of lysed cells. Similarly, the SLO treatment released only a trace amount of the GFP reporter (2 and 3%, respectively for 4 and 8 units of SLO) (Fig. 4A). This suggests that very little GFP is trafficked to the erythrocyte cytosol in these stable transfectants. By contrast, treatment of the transfectants with 0.09% saponin released the bulk of the S-antigen but did not release PfERC (Fig. 4, B and C). Interestingly, saponin released the higher molecular mass (28-kDa) GFP species but not the lower molecular mass (26-kDa) species (Fig. 4A). This indicates that the correctly processed Exp1-GFP is present as a soluble protein in the PV; however, the more extensively processed product is present in an intraparasitic compartment.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 4.   Release of EXP1-(1-35)-GFP by sub-fractionation of the transfectants. Highly synchronized transfectants, grown to trophozoite stage after synchronization (~0.5 × 108 cells), were solubilized in either 450 units (4HU) or 900 units (8HU) of SLO or 0.09% saponin and separated into supernatant (S) and pellet (P) fractions by centrifugation. These fractions were separated by SDS-PAGE (12% acrylamide), blotted onto polyvinylidene difluoride membrane, and probed with antibodies recognizing GFP (1:1000 dilution), S-antigen (1:500 dilution), and PfERC (1:500 dilution).

Trafficking of Exp1-GFP into the PV is BFA-sensitive-- Previous studies (19, 36-38) have shown that the export of proteins into the extraparasitic compartments of P. falciparum-infected erythrocytes is inhibited by BFA. In this investigation, young (ring stage) parasites were treated with BFA to determine whether the trafficking of Exp1-GFP is sensitive to this drug. As shown in Fig. 5, BFA treatment resulted in trapping of the expressed chimeric GFP protein within the parasite, whereas the control parasites exhibited the expected ring-like PV fluorescence pattern.


View larger version (84K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of brefeldin A treatment of ring stage parasites on the export of Exp1-(1-35)-GFP. Erythrocytes infected with tightly synchronized (6-10 h) ring stage transfectants were incubated for 18 h in the presence of 5 µg/ml BFA (lower panels) or an equivalent volume of methanol (control; upper panels) and examined by fluorescence microscopy. The confocal images shown (left to right) are as follows: DIC, GFP fluorescence, and an overlay. Bar, 5 µm.

Some Regions or Extensions of the PV May Be Sites of Sorting of Lipid and Protein Components-- To further examine the organization of Exp1-(1-35)-GFP within the PV, we have labeled the transfected parasites with BODIPY-TR-ceramide as described by Behari and Haldar (30). The BODIPY-TR-ceramide probe is taken up from the medium into the erythrocyte membrane and transfers to membrane structures within the infected erythrocyte cytosol (Fig. 6). Since the probe may have detergent-like properties, we have used very low levels (1 µM) of the BODIPY-TR-lipid probe (i.e. ~1 probe molecule:400 endogenous lipid molecules) in an effort to avoid disruption of the membranes of the parasitized erythrocytes. Under these conditions, only a very small amount of the ceramide was converted to sphingomyelin (data not shown) as has been reported previously (30).


View larger version (58K):
[in this window]
[in a new window]
 
Fig. 6.   Labeling of Exp1-(1-35)-GFP transfectants with BODIPY-TR-ceramide. A-D, the confocal images in each set (left to right) represent DIC, GFP fluorescence, BODIPY-TR fluorescence, and an overlay of the GFP (green) and BODIPY-TR (red) images. The Exp1-(1-35)-transfectants often show a restricted distribution of the GFP chimera within the PV. Some PV subcompartments are marked with blue arrowheads. In addition, distortions, evaginations, and loop-like extensions of the PV to form the so-called TVN were observed. Some regions and extensions of the PV contained both GFP and BODIPY-TR, whereas some (indicated with white open head arrows) contained only the BODIPY-TR probe. BODIPY-TR-labeled structures underneath the erythrocyte membrane (probably Maurer's clefts; white arrowheads) also do not contain GFP. Panels A-C are collected in a plane near the middle or upper surface of the parasite. Panel D is collected in a plane close to the lower surface of the parasite. E, Diagrammatic representation of the different structures in BODIPY-TR-labeled GFP transfectants. The Exp1 chimera is translocated into the ER and delivered to the PV. The chimera is restricted to subcompartments of the PV, possibly due to close apposition of the PPM and PVM (arrowed), which may prevent diffusion between sub-regions. Some extensions of the PV form circular compartments bound by a double membrane that can bud into the erythrocyte cytosol. Some regions of the PV/TVN appear to exclude the GFP chimera; these may be regions of sorting of PV resident proteins from proteins destined for export. The Maurer's clefts may be formed by the budding and maturation of vesicle or tubules derived from the TVN.

The BODIPY-TR-ceramide probe labeled the erythrocyte membrane and the periphery of the parasite (Fig. 6). In doubly labeled cells, it is clear that both the GFP chimera and the BODIPY-TR probe are associated with the PV; however, the lumenal Exp1-GFP protein appears to be restricted to subcompartments within the PV (Fig. 6, blue arrowheads).

The BODIPY-TR-ceramide was also present in protrusions and loops extending from the PV and in small structures attached to the erythrocyte membrane (Fig. 6, A, B, and D). The loop structures are presumably the double membrane-bound extensions of the PV known as the tubulovesicular network (30, 39) (Fig. 6E). The small structures underlying the erythrocyte membrane are likely to be Maurer's clefts (22, 40, 41) (Fig. 6E). The GFP chimera is present in some regions of the PV/TVN but is absent from others. It is possible that the regions and extensions of the PV that lack GFP (Fig. 6, white open head arrows) represent sites of sorting of components destined for trafficking beyond the PV. A diagrammatic representation of the different membrane structures in these doubly labeled cells is shown in Fig. 6E.

Organization and Dynamics of Exp1-GFP within the PV-- We have used FRAP to examine the organization and dynamics of Exp1-(1-35)-GFP within the PV and in protrusions and blebs adjacent to the PV (Fig. 7). A small region of a labeled infected erythrocyte was bleached using a high power laser pulse of 1-s duration. After the pulse, the cell was imaged immediately and at different time intervals thereafter. As seen in Fig. 7A, a 1-s bleach pulse directed onto one of the "beads" of fluorescence in the PV resulted in a loss of fluorescence that was localized to the region that was pulsed. During the 120-s postbleach period, there was 50% recovery of the fluorescence signal into the bleached area (Fig. 7F). This indicates that the bleached bead is not an isolated structure but is part of some larger structure in which diffusion of Exp1-(1-35)-GFP can occur. The degree of connectivity between different beads within the PV was investigated in greater detail using the FLIP experiment shown in Fig. 8A. A small region corresponding to one of the PV beads was exposed to a series of 1-s bleach pulses, and the loss of fluorescence intensity in other regions of the PV was examined. These data show that the population of mobile GFP chimeras that was able to repopulate the region of the bleached bead was quickly depleted. In addition, the B image demonstrates that the repeated exposure of isolated beads to the high intensity laser pulse did not produce a substantial loss of fluorescence in other regions of the PV. This indicates that whereas there is some connectivity between individual beads and a larger compartment, much of the protein population is unable to diffuse from one subcompartment to the next within the time scale examined.


View larger version (60K):
[in this window]
[in a new window]
 
Fig. 7.   FRAP measurements and analysis of GFP in doubly labeled P. falciparum-infected erythrocytes expressing Exp1-(1-35)-GFP. A-E, confocal images obtained as described under "Materials and Methods." The left panels show the DIC image of the cells. The second panel shows the BODIPY-TR image. The remaining panels show the GFP images obtained at low laser power. These images were obtained immediately prior to bleaching (Prebleach), immediately after bleaching using a high intensity laser pulse for 1 s at the position indicated by the arrow (Postbleach t0) and at times t1 and t2 after the bleach event (Postbleach t1 and Postbleach t2, respectively). A, trophozoite stage-infected erythrocyte with a "necklace of beads" fluorescence pattern; t1 = 60 s, t2 = 120 s. B, trophozoite stage-infected erythrocyte with a smooth PV fluorescence pattern; t1 = 30 s, t2 = 60 s. C and D, trophozoite stage-infected erythrocytes showing PV evaginations; t1 = 30 s, t2 = 60 s. E, a trophozoite stage-infected erythrocyte showing FV fluorescence (arrow); t1 = 30 s, t2 = 60 s. F-H, analysis of the images shown in A-C, respectively. The relative fluorescence within each outlined region (numbered) is shown as a function of time after the bleach event (data are normalized to a value of 100 in the prebleach image). The fluorescence intensities have been corrected for bleaching during image acquisition as described under "Materials and Methods." Bar, 5 µm.


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 8.   FLIP measurements and analysis of GFP in P. falciparum-infected erythrocytes expressing Exp1-(1-35)-GFP. Confocal images were obtained as described under "Materials and Methods." Trophozoite stage-infected erythrocytes showed a "necklace of beads" fluorescence pattern (A) and a smooth PV fluorescence pattern (B and C). The left panel shows the DIC images of the cells. The second panel shows the GFP fluorescence image obtained immediately prior to bleaching (PreFLIP). The region indicated by the arrow was repeatedly subjected to an intense laser pulse (1-s duration, 30-s intervals). Images were collected after the cell had been subjected to 4, 8, and 12 of these pulses (corresponding to the FLIP1, FLIP2, and FLIP3 images, respectively). The B image of the PV region shown in the right panel was constructed using the prebleach (PreFLIP) image and the postbleach images (FLIP2 in A and B and FLIP3 in C). Only those regions of the PV that did not undergo movement were analyzed. The color table for the B image is shown in Fig. 9. Bar, 5 µm.

The PV often had a smoother appearance in erythrocytes infected with more mature parasites (Fig. 7B). As with the previous example, application of a 1-s bleach pulse resulted in some loss of fluorescence in the region exposed to the high intensity laser pulse. However, in this case, the loss of fluorescence occurred throughout a larger region of the PV. After 30 s, significant recovery of fluorescence into this bleached area was observed. The analysis shown in Fig. 7G indicates that the increase in fluorescence in the bleached region is associated with a small decrease in fluorescence intensity in other regions of the PV. This suggests that the recovery of fluorescence in the bleached region may reflect the diffusion of Exp1-GFP from the unbleached regions of the PV. This was confirmed by performing a FLIP analysis on parasites exhibiting a smooth PV morphology (Fig. 8, B and C). In contrast to the observations on parasites with a "beaded" PV, repeated bleaching of one region of the PV resulted in a relatively uniform loss of fluorescence throughout the entire PV (see the respective B images). These results demonstrate that the lumen of the PV is continuous in the cells exhibiting a smooth PV appearance. It is also worth noting that in the case of each of the cells shown in Fig. 8, there were compartments adjacent to the PV that were protected from bleaching, indicating that these structures had blebbed from the PV or were not in communication with it.

The localized bleaching and the partial recovery observed over the time course of the FRAP experiment can be explained if the fusion protein exhibits a half-time for recovery on the order of seconds to tens of seconds. A similar apparent diffusion rate has been reported for another PV-located GFP chimera (19). These recovery times are significantly slower than predicted for free protein diffusion (42). The restricted diffusion could suggest that the GFP chimera is present in the form of aggregates or is associated in some way with the PVM or the PPM, although the efficient release of the chimera in saponin-treated cells argues against this interpretation. Alternatively, the restricted diffusion may be due to close apposition of the PPM and PVM in some regions, which could limit diffusion within the PV lumen.

When a looped extension of the PV/TVN was subjected to a 1-s bleach pulse (Fig. 7C) a localized loss of fluorescence was observed followed by significant recovery of fluorescence into the bleached area. The fluorescence signal recovered to ~50% within the 60-s postbleach period (Fig. 7H), indicating that this TVN extension is connected to a larger compartment, presumably the PV. Again, however, the relatively slow half-time for recovery indicates that there are some restrictions to diffusion through the solute continuum between the TVN and the PV proper. Moreover, in some cells, the extensions appear to have lost the continuum with the PV. As shown in Fig. 7D, there was no recovery of the arrowed PV extension after the bleach pulse. Blebbing of regions of the TVN has been reported previously (19).

We also found that the GFP chimera that is located within the FV is not connected by a solute continuum to the PV. As shown in Fig. 7E, bleaching of the FV compartment did not affect the fluorescence signal from the PV, and there was no recovery of signal into the FV within the 120-s postbleach period. Interestingly, bleaching of the FV compartment revealed another compartment within the parasite that contains the GFP chimera (Fig. 7E, asterisk). This may represent an endocytic packet of the PV en route to the FV or a subcompartment within the parasite secretory system en route to the PV.

We have also used FRAP analysis to examine the organization and dynamics of the BODIPY-TR-ceramide probe. An examination of doubly labeled cells confirmed the observation that some of the BODIPY-TR-labeled membrane compartments had separated from the PV (Fig. 9A, upper panel). These structures were often observed to colocalize with the GFP chimera (Fig. 9A, arrow in lower panel) and to exhibit mobility within the erythrocyte cytosol when monitored over time (Fig. 9A, lower panels). Since the GFP chimera is likely to be present in an aqueous environment within these structures, the colocalization indicates that these structures comprise a double membrane that encloses two lumenal compartments, with the GFP chimera located in the outer lumen. The inability to resolve the two bilayers reflects the close apposition of the membranes to form a thin outer lumen whose dimensions are below the level of resolution available using the confocal microscope. Such structures are presumably formed by circularization of extensions of the PV/TVN as shown in Fig. 6E. Similar structures have been observed by EM (39). The absence of a lipid continuum between these structures and the PVM was confirmed by the FRAP experiment shown in Fig. 9A (upper panel). High intensity illumination of the structure at the excitation wavelength of the BODIPY-TR probe resulted in almost complete ablation of the BODIPY-TR fluorescence in this structure but had little effect on the fluorescence signal from the other membranes. In addition, there was insignificant recovery of fluorescence into the structure over a 1-min period. These results are consistent with a loss of connectivity to the PVM and other parasite membranes.


View larger version (53K):
[in this window]
[in a new window]
 
Fig. 9.   FRAP measurements and analysis of BODIPY-TR in doubly labeled P. falciparum-infected erythrocytes expressing Exp1-(1-35)-GFP. Panels on the extreme left show DIC images. The upper (red) and lower (green) panels show the respective BODIPY-TR and GFP images that were obtained during the course of the FRAP measurement. These show the prebleach image, the image obtained immediately after bleaching using a high intensity laser pulse (568 nm) for 1 s at the position indicated by the arrow, and the images obtained 30 and 60 s after the bleach event. A, trophozoite stage-infected erythrocyte showing a double membrane-bound structure that has budded from the PV (arrow). B, trophozoite stage-infected erythrocyte showing PV evaginations. The B image shown on the right was constructed from the BODIPY-TR prebleach and bleach images. The QR image was constructed using the prebleach, bleach, and 60-s postbleach images as described under "Materials and Methods." Bar, 5 µm.

In other cases, some of these structures appeared to remain connected to the PV. As shown in Fig. 9B, a high intensity pulse of 1-s duration directed at the tip of an extension of the PV resulted in partial bleaching of the BODIPY-TR signal in this compartment. In contrast to the previous example, the degree of fluorescence loss at the bleach site was limited, and the bleached area extended throughout a large area of the PV proximal to the illuminated region (see B image). This is consistent with significant diffusion of BODIPY-TR-ceramide occurring during the bleach time and image acquisition time and is in the correct range for the diffusion of a membrane lipid (42). This is further confirmed by the QR image shown in Fig. 9, which shows that there is subsequent recovery into the bleached region. These data indicate that the protrusion is connected to the PVM by a lipid continuum. The laser pulse also caused some bleaching of an adjacent region of the erythrocyte membrane. Diffusion of the probe within the host cell membrane allowed recovery of fluorescence in this compartment on a similar time scale. It is important to note that the bleach pulse had no effect on the fluorescence signal from the GFP chimera in this doubly labeled cell (Fig. 9B, bottom panels).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Proteins destined for extraparasitic locations in malaria parasite-infected erythrocytes are thought to transit through the ER and the PV prior to transfer to the erythrocyte cytosol (19, 43, 44); however, the nature of the polypeptide secretory signals that direct proteins to their correct destinations is currently the subject of some debate. An analysis of the sequences of exported parasite proteins reveals some rather unusual motifs. Proteins that are destined for sites within the confines of the PVM have classical hydrophobic N-terminal signal sequences (i.e. a stretch of 10-15 hydrophobic amino acids close to the N terminus). By contrast, many proteins that are directed past the PVM to the erythrocyte cytosol do not have classical N-terminal signals. Proteins such as KAHRP, the mature parasite-infected erythrocyte surface antigen and the ring-infected erythrocyte surface antigen have a hydrophobic stretch of amino acids starting 20-80 amino acids from the N terminus (see Table I in Ref. 43). An exception to this rule is HRP2, which has a classical hydrophobic signal and yet is largely located in the erythrocyte cytosol (45, 46). It is possible that information determining the final destination of the protein is contained within the N-terminal signal. Alternatively, both classical and recessed hydrophobic signal sequences may function interchangeably to direct the translocation of proteins into the ER (with the PV as the default destination), with additional trafficking information encoded elsewhere in the polypeptide sequence. Work from Wickham et al. (19) indicated that the noncanonical signal sequence of KAHRP is sufficient for transport to the PV but that additional signal information is needed for export beyond this point. By contrast, the work of Burghaus and Lingelbach (22) suggested that the classical signal sequence of Exp1 directed a chimera to the erythrocyte cytosol. They proposed that the erythrocyte cytosol is the default destination and that additional signal information is needed to retain proteins in the PV.

In this work, we have reexamined the trafficking signals within the exported protein, Exp1. Exp1 was originally described as an antigen of P. falciparum that is transported from the parasite to the PVM and, to some extent, to membrane-bound compartments in the erythrocyte cytosol (14, 23, 24, 33). Exp1 is an integral membrane protein with the C-terminal domain facing the erythrocyte cytosol (14). We prepared a chimeric gene construct encoding an N-terminal fragment of Exp1 linked to the reporter protein, GFP. The construct was successfully used to prepare stably transfected P. falciparum. The transfectants were readily maintained in culture and continued to express the fluorescent protein even under very low drug pressure. This suggests that the expression of the GFP chimera did not compromise the growth of the parasites. Western analysis indicated that part of the population of Exp1-(1-35)-GFP was processed to a 28-kDa product, presumably by removal of the N-terminal signal by a signal peptidase in the ER, while part of the population was further processed to a 26-kDa species.

Using confocal fluorescence microscopy, we have shown that the Exp1-(1-35)-GFP chimera is present in the parasite PV and in extensions of the PV as well as in a compartment within the parasite cytoplasm. There appears to be little or no GFP released into the erythrocyte cytosol. To confirm the location of the chimera, we have subfractioned the parasitized erythrocytes using selective permeabilization protocols. The pore-forming toxin, SLO, inserts into the erythrocyte membrane and releases the soluble erythrocyte components but leaves the PV intact (21, 28, 29). By contrast, saponin, a detergent that interacts with cholesterol, disrupts the erythrocyte membrane and the PVM but leaves the PPM intact (21, 47). Saponin lysis of the transfectants released the 28-kDa form of the GFP chimera but did not release the 26-kDa form. This indicates that the 28-kDa product is present in the PV but that the 26-kDa product is located in a site within the confines of the PPM. When the fractionation data are taken together with the fluorescence microscopy data (which show that some of the GFP is localized near the hemozoin crystal) and with previous electron microscopy (EM) studies (19), the data indicate that some of the chimera is correctly processed and trafficked to the PV, while a proportion of the population is diverted to (or endocytosed into) the FV, where it is further degraded. Previous studies have shown that the core of GFP forms a highly stable beta -barrel structure that may resist proteolytic degradation (48). Western analysis of the relative levels of the 26- and 28-kDa species indicates that a significant proportion of the GFP chimera (~50%) is present in the FV. However, the fluorescence from this compartment was usually less than that from the PV. This may reflect the larger volume of the FV and/or be due to the acidic environment of the FV (49) quenching the fluorescence of the GFP (50).

Our data show that the PV is the default destination for export of proteins from the malaria parasite. Taken together with the work of Wickham et al. (19), the data indicate that both classical and recessed N-terminal signal sequences of malaria proteins contain information only for entry into the ER (and hence default secretion to the PV), whereas additional sequence information is needed to direct proteins past this point. This is in direct contrast to the data of Burghaus and Lingelbach (22), who reported that an Exp1-luciferase chimera was largely directed to the erythrocyte cytosol. This discrepancy may be explained by the different approach taken by Burghaus and Lingelbach (22). For example, they used a transient transfection system and used luciferase as a reporter. Since protocols for the transfection of P. falciparum are very inefficient (about 1 in 100,000 for transient transfection and 1 in a million for stable transfection (see Refs. 51 and 52), Burghaus and Lingelbach (22) relied on a cell fractionation protocol and the very high sensitivity of the luciferase reporter to detect the chimeric product in parasites 3 days after the transfection protocol. In our study, we used a dual cassette transfection construct that, in addition to the transgene, encodes human DHFR, which confers resistance to WR99210. We cultured the parasites for several months in the presence of drug and thus obtained a transfectant stably expressing the chimeric protein from an episome. It is possible that, in the transient transfection system, the electroporation protocols used to introduce the plasmid or initial high copy numbers of the plasmid in some cells compromised the integrity of the parasite membranes, allowing release of the fusion protein into the erythrocyte cytosol. Also, it is interesting to note that luciferase carries a SKL sequence at its C terminus that functions as a peroxisomal import sequence in higher eukaryotes (53). Thus, it is possible that this motif or another cryptic motif within the luciferase reporter is responsible for translocation of the chimera into the erythrocyte cytosol.

The export of Exp1-(1-35)-GFP is sensitive to brefeldin A. This indicates that the protein transits through the ER before secretion into the PV. The Western blot analysis and the selective permeabilization studies are consistent with the suggestion that the N-terminal signal has been removed during trafficking of Exp1-(1-35)-GFP through the ER. Since the Exp1-GFP chimeric construct lacks the transmembrane domain, it is likely that it exists as a soluble protein in the lumen of the PV. Nonetheless, the GFP chimera often appeared to be restricted to subdomains of the PV. For example, the fusion protein often appeared to reside in bead-like subcompartments forming a "necklace" around the parasite. To examine the nature of the PV subcompartments, we have used BODIPY-TR-ceramide, which appears to preferentially label membrane components of the PVM/TVN. The dual labeling of live cells showed that some regions and extensions of the PV/TVN contained both GFP and the BODIPY-TR lipid probe; however, in other regions there appeared to be a segregation of the lipid and protein probes.

Photobleaching studies allow an analysis of the organization and dynamics of fluorescent components in living cells (42). In this work, we have used photobleaching protocols to examine the diffusional properties of GFP in the PV. Theoretical considerations predict that unrestricted diffusion of soluble Exp1-(1-35)-GFP molecules would be sufficiently rapid to allow complete equilibration of the protein throughout the PV compartment within the 1-s bleach time employed in this study. This would result in an even loss of fluorescence throughout a continuous compartment the size of the PV (42). The observation that a bleach pulse at the PV produces a local loss of fluorescence that subsequently recovers shows that the diffusion of the GFP chimera in the PV is considerably slower than in free solution. In GFP-labeled cells that exhibited a smooth PV appearance, these slowly diffusing GFP molecules were free to equilibrate throughout the entire PV lumen. This was not the case in GFP-labeled cells that exhibited a PV with a beaded morphology. In these cells, it appeared that the Exp1-GFP was located in subcompartments within the PV and that there was little or no diffusion between these subcompartments on the time scale of the measurements. This provides a direct demonstration of unlinked subcompartments within the PV. We propose that the barrier to GFP diffusion arises from a constriction of the PV lumenal space due to the close apposition of the PPM and PVM in some regions (Fig. 6E). These constrictions are presumably responsible for the "string of beads" appearance of the PV.

Part of the population of chimeric GFP molecules appears to be directed to the FV. This may represent an overflow pathway for proteins en route through the secretory system. Alternatively, it is possible that the GFP fusion proteins are taken up during the parasite's feeding process. The parasite uses a cytostome (mouth) to ingest small packets of hemoglobin from the host cytoplasm. These endocytic compartments are surrounded by a double membrane originating from the PPM and the PVM and thus are likely to contain proteins from the PV as well as the erythrocyte cytoplasm (Fig. 6E). These vesicles are transported to and fuse with the FV, which would deliver the fusion proteins to this compartment. In some cells, bleaching of the FV-located GFP chimera revealed the presence of other structures within the parasite cytosol; these may represent endocytic or secretory vesicles.

In more mature stage parasites, the GFP chimera was often present in looped extensions of the PV. Bleaching of a PV extension was often followed by gradual recovery of the signal, which indicates that these protrusions remain connected to the PV. However, some of the evaginations appeared to be closed compartments; photobleaching of these blebs did not cause a loss of fluorescence signal throughout the PV, and no recovery was observed. This indicates a physical barrier to diffusion of the chimera between the evaginated region and the PV. In some cases, the GFP-Exp1 chimera is packaged into double membrane-bound compartments that are released from the PV. Membrane-bound structures containing endogenous Exp1 have been observed in the erythrocyte cytosol using immunofluorescence microscopy (14, 15). These budded double membrane-bound compartments were quite frequently observed in trophozoite stage parasites; however, they did not connect or fuse with the erythrocyte membrane. This suggests that that these PV lumen-containing structures probably do not play a direct role in delivery of proteins to the erythrocyte membrane. This is in agreement with previous studies (19, 36). However, we also observed regions of the PV and protrusions emanating from the PV that were labeled with the BODIPY-TR-ceramide probe but that excluded the GFP chimera. These regions may represent sites for sorting of PV-resident proteins from proteins destined for transport to the erythrocyte membrane. PV resident-free structures may bud from the PV as vesicles or tubules and mature to form the Maurer's clefts.

The photobleaching data provide information about the organization of the membranous structures in the erythrocyte cytosol that add to previous EM and fluorescence microscopy studies. Previous studies have revealed the presence of large circular double membrane-bound compartments and large multiple membrane whorls (the so-called TVN) that remain connected to the PV (30, 54, 55). Our data support at least partial connectivity between the PV and the TVN, although blebbing of the TVN also appears to occur. Maurer's clefts have been reported to be interconnected subcompartments of the TVN complex (30, 54). However, our data suggest that they are separate compartments.

Taken together with previous studies, our data allow us to build a picture of protein export in infected erythrocytes. Proteins with either classical or recessed signal sequences are routed through the ER to the PV, with concomitant cleavage of the signal peptide. Proteins that lack additional sequence signals remain in the PV, whereas recognition of a "translocation motif" in exported proteins, such as KAHRP, results in translocation of these proteins across the PVM, probably via an ATP-dependent transporter (21). Integral membrane proteins such as PfEMP1 that are destined for the erythrocyte membrane are presumably incorporated into vesicles or tubules that bud from specialized regions of the PV that exclude PV-resident proteins. The PfEMP1-containing structures are presumably trafficked to (or mature to become) the Maurer's clefts, and then PfEMP1 is transferred to the erythrocyte membrane. The Maurer's clefts contain homologues of components of the classical secretory pathway such as Sar1p (13, 19), Sec31p (26), and a component SNARE-mediated fusion process, NSF (56), which may be involved in the sorting of proteins destined for the erythrocyte membrane. Therefore, it appears likely that trafficking between these compartments is vesicle-mediated. Indeed, vesicle-like structures that may be involved in the trafficking of proteins from the PVM (44) and the Maurer's clefts2 have been identified at the EM level.

In summary, we have shown that by tagging a parasite protein of interest at the gene level with GFP it is possible to decipher the signals that target proteins to specific compartments of the infected erythrocyte. In addition, the GFP transfectants were used to monitor the location and organization of the labeled component in live parasites during the course of the cell cycle. Use of photobleaching techniques enabled us to identify novel subcompartments within the PV. This has allowed an increased understanding of the nature of the pathway for protein trafficking in parasitized erythrocytes. The unusual characteristics of the external sector of this pathway make it a potential target for new antimalarial strategies.

    ACKNOWLEDGEMENTS

Expert technical assistance was provided by Emma Fox. We thank Prof. Robin Anders and Prof. Klaus Lingelbach for providing antibodies and for useful discussions.

    FOOTNOTES

* This work was supported by the National Health and Medical Research Council, Australia.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed. Tel.: 61-3-94791375; Fax: 61-3-94792467; E-mail: L.Tilley@LaTrobe.edu.au.

Published, JBC Papers in Press, November 26, 2002, DOI 10.1074/jbc.M207039200

2 L. Tilley, N. Kriek, D. Ferguson, and C. Newbold, unpublished data.

    ABBREVIATIONS

The abbreviations used are: ER, endoplasmic reticulum; BFA, brefeldin A; BODIPY-TR-ceramide, N-((4-(4,4-difluoro-5-(2-thienyl)-4-bora-3a,4a-diaza-s-indacene-3-yl)phenoxy)acetyl)sphingosine; DIC, differential interference contrast; PPM, parasite plasma membrane; Exp1, exported protein-1; GFP, green fluorescent protein; KAHRP, knob-associated histidine-rich protein; PVM, parasitophorous vacuolar membrane; PfEMP1, P. falciparum erythrocyte membrane protein-1; PfERC, P. falciparum endoplasmic reticulum-located calcium-binding protein; SLO, streptolysin O; TVN, tubulovesicular network; NSF, N-ethylmaleimide-sensitive factor; SNARE, soluble NSF attachment protein receptor; PV, parasitophorous vacuole; FRAP, fluorescence recovery after photobleaching; FLIP, fluorescence loss in photobleaching; FV, food vacuole; EM, electron microscopy.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Blobel, G. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 1496-1500[Abstract]
2. von Heijne, G. (1985) J. Mol. Biol. 184, 99-105[Medline] [Order article via Infotrieve]
3. Nielsen, H., Engelbrecht, J., Brunak, S., and von Heijne, G. (1997) Protein Eng. 10, 1-6[Abstract]
4. Martoglio, B., and Dobberstein, B. (1998) Trends Cell Biol. 8, 410-415[CrossRef][Medline] [Order article via Infotrieve]
5. Hegde, R. S., and Lingappa, V. R. (1999) Trends Cell Biol. 9, 132-137[CrossRef][Medline] [Order article via Infotrieve]
6. DeRocher, A., Hagen, C. B., Froehlich, J. E., Feagin, J. E., and Parsons, M. (2000) J. Cell Sci. 113, 3969-3977[Abstract/Free Full Text]
7. Schwartzbach, S. D., Osafune, T., and Loffelhardt, W. (1998) Plant Mol. Biol. 38, 247-263[CrossRef][Medline] [Order article via Infotrieve]
8. Waller, R. F., Reed, M. B., Cowman, A. F., and McFadden, G. I. (2000) EMBO J. 19, 1794-1802[Abstract/Free Full Text]
9. Lingelbach, K. R. (1993) Exp. Parasitol. 76, 318-327[CrossRef][Medline] [Order article via Infotrieve]
10. Foley, M., and Tilley, L. (1998) Int. J. Parasitol. 28, 1671-1680[CrossRef][Medline] [Order article via Infotrieve]
11. van Dooren, G. G., Waller, R. F., Joiner, K. A., Roos, D. S., and McFadden, G. I. (2000) Parasitol. Today 16, 421-427[CrossRef][Medline] [Order article via Infotrieve]
12. von Heijne, G. (1986) Nucleic Acids Res. 14, 4683-4690[Abstract]
13. Albano, F. R., Berman, A., La, Greca, N., Hibbs, A. R., Wickham, M., Foley, M., and Tilley, L. (1999) Eur. J. Cell Biol. 78, 453-462[Medline] [Order article via Infotrieve]
14. Gunther, K., Tummler, M., Arnold, H. H., Ridley, R., Goman, M., Scaife, J. G., and Lingelbach, K. (1991) Mol. Biochem. Parasitol. 46, 149-158[CrossRef][Medline] [Order article via Infotrieve]
15. Kara, U., Murray, B., Pam, C., Lahnstein, J., Gould, H., Kidson, C., and Saul, A. (1990) Mol. Biochem. Parasitol. 38, 19-23[Medline] [Order article via Infotrieve]
16. Mattei, D., Berry, L., Couffin, S., and Richard, O. (1999) Novartis Found. Symp. 226, 215-230[Medline] [Order article via Infotrieve]
17. Kilejian, A., Sharma, Y. D., Karoui, H., and Naslund, L. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 7938-7941[Abstract]
18. Hinterberg, K., Scherf, A., Gysin, J., Toyoshima, T., Aikawa, M., Mazie, J. C., Dasilva, L. P., and Mattei, D. (1994) Exp. Parasitol. 79, 279-291[CrossRef][Medline] [Order article via Infotrieve]
19. Wickham, M. E., Rug, M., Ralph, S. A., Klonis, N., McFadden, G. I., Tilley, L., and Cowman, A. F. (2001) EMBO J. 20, 5636-5649[Abstract/Free Full Text]
20. Reed, M. B., Saliba, K. J., Carauna, S. R., Kirk, K., and Cowman, A. F. (2000) Nature 403, 906-909[CrossRef][Medline] [Order article via Infotrieve]
21. Ansorge, I., Benting, J., Bhakdi, S., and Lingelbach, K. (1996) Biochem. J. 315, 307-314[Medline] [Order article via Infotrieve]
22. Burghaus, P. A., and Lingelbach, K. (2001) J. Biol. Chem. 276, 26838-26845[Abstract/Free Full Text]
23. Simmons, D., Woollett, G., Bergin-Cartwright, M., Kay, D., and Scaife, J. (1987) EMBO J. 6, 485-491[Abstract]
24. Hope, I. A., Mackay, M., Hyde, J. E., Goman, M., and Scaife, J. (1985) Nucleic Acids Res. 13, 369-379[Abstract]
25. Fidock, D. A., and Wellems, T. E. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 10931-10936[Abstract/Free Full Text]
26. Adisa, A., Albano, F. R., Reeder, J., Foley, M., and Tilley, L. (2001) J. Cell Sci. 114, 3377-3386[Abstract/Free Full Text]
27. Aley, S. B., Sherwood, T. A., Marsh, D., Eidelman, O., and Howard, R. J. (1986) Parasitology 92, 511-525[Medline] [Order article via Infotrieve]
28. Baumeister, S., Paprotka, K., Bhakdi, S., and Lingelbach, K. (2001) Mol. Biochem. Parasitol. 112, 133-137[CrossRef][Medline] [Order article via Infotrieve]
29. Ansorge, I., Paprotka, K., Bhakdi, S., and Lingelbach, K. (1997) Mol. Biochem. Parasitol. 84, 259-261[CrossRef][Medline] [Order article via Infotrieve]
30. Behari, R., and Haldar, K. (1994) Exp. Parasitol. 79, 250-259[CrossRef][Medline] [Order article via Infotrieve]
31. Haldar, K., Uyetake, L., Ghori, N., Elmendorf, H. G., and Li, W. L. (1991) Mol. Biochem. Parasitol. 49, 143-156[CrossRef][Medline] [Order article via Infotrieve]
32. Wu, Y., Sifri, C. D., Lei, H. H., Su, X. Z., and Wellems, T. E. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 973-977[Abstract]
33. Coppel, R., Favaloro, J., Crewther, P., Burkot, T., Bianco, E., Stahl, H., Kemp, D., Anders, R., and Brown, G. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 5121-5125[Abstract]
34. La Greca, N., Hibbs, A. R., Riffkin, C., Foley, M., and Tilley, L. (1997) Mol. Biochem. Parasitol. 89, 283-293[CrossRef][Medline] [Order article via Infotrieve]
35. Culvenor, J. G., and Crewther, P. E. (1990) J. Protozool. 37, 59-65[Medline] [Order article via Infotrieve]
36. Elmendorf, H. G., and Haldar, K. (1994) J. Cell Biol. 124, 449-462[Abstract]
37. Benting, J., Mattei, D., and Lingelbach, K. (1994) Biochem. J. 300, 821-826[Medline] [Order article via Infotrieve]
38. Nacer, A., Berry, L., Slomianny, C., and Mattei, D. (2001) Int. J. Parasitol. 31, 1371-1379[CrossRef][Medline] [Order article via Infotrieve]
39. Elford, C. B., Cowan, M. G., and Ferguson, P. J. D. (1995) Biochem. J. 308, 361-374[Medline] [Order article via Infotrieve]
40. Gormley, J. A., Howard, R. J., and Taraschi, T. F. (1992) J. Cell Biol. 119, 1481-1495[Abstract]
41. Sam-Yellowe, T. Y., Fujioka, H., Aikawa, M., Hall, T., and Drazba, J. A. (2001) Parasitol. Res. 87, 173-185[Medline] [Order article via Infotrieve]
42. Klonis, N., Rug, M., Harper, I., Wickham, M., Cowman, N., and Tilley, L. (2002) Eur. Biophys. J. 31, 36-51[CrossRef][Medline] [Order article via Infotrieve]
43. Albano, F. R., Foley, M., and Tilley, L. (1999) Novartis Found. Symp. 226, 157-172[Medline] [Order article via Infotrieve]
44. Taraschi, T. F., Trelka, D., Martinez, S., Schneider, T., and O'Donnell, M. E. (2001) Int. J. Parasitol. 31, 1381-1391[CrossRef][Medline] [Order article via Infotrieve]
45. Howard, R. J., Uni, S., Aikawa, M., Aley, S. B., Leech, J. H., Lew, A. M., Wellems, T. E., Rener, J., and Taylor, D. W. (1986) J. Cell Biol. 103, 1267-1277
46. Papalexis, V., Siomos, M. A., Campanale, N., Guo, X. G., Kocak, G., Foley, M., and Tilley, L. (2001) Mol. Biochem. Parasitol. 115, 77-86[CrossRef][Medline] [Order article via Infotrieve]
47. Saliba, K. J., Horner, H. A., and Kirk, K. (1998) J. Biol. Chem. 273, 10190-10195[Abstract/Free Full Text]
48. Ormo, M., Cubitt, A. B., Kallio, K., Gross, L. A., Tsien, R. Y., and Remington, S. J. (1996) Science 273, 1392-1395[Abstract]
49. Krogstad, D. J., Schlesinger, P. H., and Gluzman, I. Y. (1985) J. Cell Biol. 101, 2301-2309
50. Patterson, G. H., Knobel, S. M., Sharif, W. D., Kain, S. R., and Piston, D. W. (1997) Biophys. J. 73, 2782-2790[Abstract]
51. Crabb, B. S., Triglia, T., Waterkeyn, J. G., and Cowman, A. F. (1997) Mol. Biochem. Parasitol. 90, 131-144[CrossRef][Medline] [Order article via Infotrieve]
52. O'Donnell, R. A., Freitas-Junior, L. H., Preiser, P. R., Williamson, D. H., McElwain, T. F., Scherf, A., Cowman, A. F., and Crabb, B. S. (2002) EMBO J. 21, 1231-1239[Abstract/Free Full Text]
53. Miura, S., Kasuya-Arai, I., Mori, H., Miyazawa, S., Osumi, T., Hashimoto, T., and Fujiki, Y. (1992) J. Biol. Chem. 267, 14405-14411[Abstract/Free Full Text]
54. Bannister, L. H., Hopkin, J. M., Fowler, R. E., Krishna, S., and Mitchell, G. H. (2000) Parasitol. Today 16, 427-433[CrossRef][Medline] [Order article via Infotrieve]
55. Howard, R. J. (1988) in The Biology of Parasitism (Englund, P. , and Sher, A., eds) , pp. 111-145, Alan R. Liss Inc., New York
56. Hayashi, M., Taniguchi, S., Ishizuka, Y., Kim, H. S., Wataya, Y., Yamamoto, A., and Moriyama, Y. (2001) J. Biol. Chem. 276, 15249-15255[Abstract/Free Full Text]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.